Delivery & Monitoring Platform
Current challenges in drug delivery
-
Difficulty delivering past the Blood Brain Barrier, Blood-CSF, and Blood Arachnoid barriers. [1]
-
Difficulty delivering to localized areas in the CNS
EnClear will improve therapeutic delivery through our ability to:
-
Enable Targeted delivery through optimized flow rate, pulse width, volume, and controlled CSF recirculation
-
Deliver at multiple access points within the CNS (e.g., lumbar, ventricular)
EnClear's Advantage
-
Localized delivery past the BBB to areas of the CNS most benefited by therapeutics
-
Controlled, continuous, and personalized therapeutic distribution in the CNS
* The EnClear platform is in early development, statements are currently under investigation.
1.https://www.cell.com/trends/chemistry/fulltext/S2589-5974(19)30100-5